(3beta,16alpha)-16-hydroxy-13,28-epoxyoleanan-3-yl alpha-L-Rhap-(1->2)-beta-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-alpha-L-arabinopyranoside

Term ID

CHEBI:66425

Synonyms

(3beta,16alpha)-16-hydroxy-13,28-epoxyoleanan-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-alpha-L-arabinopyranoside

Definition

A triterpenoid saponin isolated from Myrsine australis and Ardisia japonica and has been shown to exhibit antineoplastic activity.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: bridged compound hexacyclic triterpenoid tetrasaccharide derivative triterpenoid saponin

bridged compound hexacyclic triterpenoid tetrasaccharide derivative triterpenoid saponin Show first 5 Terms
has_role: antineoplastic agent plant metabolite

antineoplastic agent plant metabolite Show first 5 Terms

Phenotype

Phenotype resulting from (3beta,16alpha)-16-hydroxy-13,28-epoxyoleanan-3-yl alpha-L-Rhap-(1->2)-beta-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-alpha-L-arabinopyranoside

Phenotype where environments contain (3beta,16alpha)-16-hydroxy-13,28-epoxyoleanan-3-yl alpha-L-Rhap-(1->2)-beta-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-alpha-L-arabinopyranoside

Phenotype modified by environments containing (3beta,16alpha)-16-hydroxy-13,28-epoxyoleanan-3-yl alpha-L-Rhap-(1->2)-beta-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-alpha-L-arabinopyranoside

Human Disease Model